Moolec Science (MLECW) Stock Price, News & Analysis

Company Overview

Moolec Science K.K. is a Tokyo-based biotechnology company focused on the research and development of messenger RNA (mRNA) therapeutics and vaccines. Founded in 2018, the company leverages a proprietary cell-free mRNA manufacturing platform designed to streamline production and enhance the stability and scalability of mRNA drug candidates. In December 2021, Moolec Science commenced trading on the Nasdaq Global Market under the ticker symbol MLECW, marking its transition into a publicly listed entity.

Moolec Science’s core activities center on the discovery, optimization and clinical advancement of mRNA-based products across several therapeutic areas. The company’s pipeline includes vaccine candidates targeting infectious diseases as well as mRNA constructs for cancer immunotherapy. By integrating in-house process development with analytical and formulation capabilities, Moolec Science aims to address key challenges in mRNA delivery and manufacturability, positioning itself as a vertically integrated partner for both internal programs and external collaborators.

Headquartered in Tsukuba City, Ibaraki Prefecture, Japan, Moolec Science maintains strategic links with academic and industry research institutions to accelerate preclinical validation and clinical translation. The company serves markets in Asia, North America and Europe, leveraging a growing network of partnerships to support global development efforts. Through its proprietary platform and collaborative approach, Moolec Science is pursuing scalable solutions for next-generation mRNA therapeutics.

Key Stats

• Today's Range: $0.0103 to $0.0146
• 50-Day Range: $0.01 to $0.02
• 52-Week Range: $0.01 to $0.07
• Volume: 2,790 shs
• Average Volume: 26,672 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MLECW Stock Analysis - Frequently Asked Questions

How have MLECW shares performed this year?

Moolec Science's stock was trading at $0.0254 on January 1st, 2025. Since then, MLECW stock has decreased by 50.8% and is now trading at $0.0125.

How do I buy shares of Moolec Science?

Shares of MLECW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Trading
• Current Symbol: NASDAQ:MLECW
• CIK: 1937737
• Web: moolecscience.com
• Phone: 352-26-49-65-65
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $7.83 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A